NY Times

NOVEMBER 10, 2020

The German company BioNTech, founded by two scientists, has teamed up with Pfizer on a vaccine that was found to be more than 90 percent effective.

Vaccines 145

Vaccines 145

Outsourcing Pharma

NOVEMBER 12, 2020

A leader from the AI technology firm discusses how life-sciences pros are harnessing AI to help continue their work in the face of the pandemic.

139

139

pharmaphorum

NOVEMBER 11, 2020

Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceutical companies, and patient treatment. With AI already the key engine for a growing list of consumer devices, the trend has created exciting opportunities for pharma and healthcare. “We have now entered a new phase of AI implementation where AI-based technology is expected to be foundational and not just a novel technology,” Abid Rahman, vice president, innovation,

Pharmaceutical Companies 129

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 129

Drug Patent Watch

NOVEMBER 10, 2020

We prefer simple flat-rate unrestricted subscriptions — we’ll work on your terms, and with your favorite subscription contract template, to find a solution that fits. If your colleagues would like to…. The post Thinking of signing your company up for DrugPatentWatch? appeared first on DrugPatentWatch - Make Better Decisions.

109

109

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharma Times

NOVEMBER 12, 2020

Interim data analysis comes from phase III clinical trials in the Russian Federation

Vaccines 124

Vaccines 124

NY Times

NOVEMBER 8, 2020

Researchers ended a clinical trial of the drug early because the results were so convincing. The more effective drug would be given in six injections a year instead of as 365 daily pills.

89

89

Outsourcing Pharma

NOVEMBER 12, 2020

The two companies plan to work together on the creation a drug-development technology tool that helps in safety margin risk assessment prediction.

Drug Development 98

Drug Development 98

Pharma Times

NOVEMBER 9, 2020

Phase III study of vaccine candidate involved 43,538 participants

Vaccines 135

Vaccines 135

NY Times

NOVEMBER 11, 2020

La compañía alemana BioNTech, fundada por dos científicos, se ha asociado con Pfizer en una vacuna cuya eficacia se ha comprobado en más de un 90 por ciento.

70

70

pharmaphorum

NOVEMBER 9, 2020

Novo Nordisk has agreed to buy Emisphere Technologies for $1.8 billion, as it continues its quest to develop diabetes medicines that can be taken as pills. Copenhagen-based Novo Nordisk already markets Rybelsus (semaglutide), a version of its GLP-1 class drug that can help to control blood sugar levels in patients with type 2 disease. But the company has tried and failed to produce insulin that can be taken orally – this proved unfeasible due to the high doses of the hormone that were needed for

Diabetes 111

Diabetes 111

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Outsourcing Pharma

NOVEMBER 10, 2020

The two companies have joined forces to collaborate on the commercial launch of Gimoti, a nasal spray for patients suffering from diabetic gastroparesis.

Diabetes 89

Diabetes 89

Pharma Times

NOVEMBER 13, 2020

Agreement follows positive phase III data announcement

Vaccines 132

Vaccines 132

NY Times

NOVEMBER 9, 2020

What’s the big deal? Was it part of Operation Warp Speed? When can you get one?

Vaccines 98

Vaccines 98

pharmaphorum

NOVEMBER 11, 2020

In the first episode of our Health Innovators series, Paul Tunnah speaks to David Van Sickle, CEO of Propeller Health about how digital technologies are revolutionising the field of respiratory medicine. The post Health Innovators: David Van Sickle on digital innovation in respiratory medicine appeared first on.

111

111

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Outsourcing Pharma

NOVEMBER 10, 2020

Preliminary results from a recent clinical trial indicate the drug touted by US leaders as a possible treatment offers no significant benefit to patients.

Hospitals 85

Hospitals 85

Pharma Times

NOVEMBER 10, 2020

Akcea’s Waylivra approved via ultra-orphan pathway

130

130

NY Times

NOVEMBER 9, 2020

The authorization raised immediate questions about who would get access to the antibody treatments, which are in short supply.

73

73

pharmaphorum

NOVEMBER 12, 2020

CatalYm has closed a €50 million ($59m) series B financing round to fund clinical studies of its immunotherapy targeting Growth Differentiation Factor 15 (GDF-15). The round was led by Vesalius Biocapital III, with participation from Novartis Venture Fund (NVF), Wachstumsfonds Bayern, coparion and founding investors Forbion and BioGeneration Ventures.

Immunization 105

Immunization Immunity Compounding 105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Outsourcing Pharma

NOVEMBER 9, 2020

President-elect Joe Biden has launched a Transition COVID-19 Advisory Board to support the USâ COVID-19 response.

97

97

Pharma Times

NOVEMBER 11, 2020

Detailed results are due to be presented at forthcoming medical meeting

112

112

NY Times

NOVEMBER 13, 2020

A new study shows that more than half of enrollees don’t review or compare their coverage options annually.

77

77

pharmaphorum

NOVEMBER 13, 2020

Hungary is to order a consignment of Russia’s Sputnik V COVID-19 vaccine, as the country struggles to contain the infection rate. According to press reports , the decision puts Hungary on “collision course” with the EU, which has not approved the vaccine or plans to review it either. The European Medicines Agency has announced rolling reviews of vaccines from mainstream pharma companies including Pfizer/BioNTech and AstraZeneca, which allow regulators to review data in real time, allowing them t

Vaccines 113

Vaccines 113

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Drug Patent Watch

NOVEMBER 9, 2020

This chart shows the pharmaceutical companies with the most elixir dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most elixir dosed drugs…. The post Which pharmaceutical companies have the most elixir dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 53

Pharmaceutical Companies Pharmaceutical Companies Dosage 53

Pharma Times

NOVEMBER 10, 2020

RECOVERY study will assess if drug can reduce risk of blood clots

116

116

Outsourcing Pharma

NOVEMBER 9, 2020

According to a survey by trial solutions company Greenphire, patient recruitment and enrollment levels have bounced back since the pandemic struck.

59

59

pharmaphorum

NOVEMBER 12, 2020

The European Union has ordered 300 million doses of BioNTech/Pfizer’s COVID-19 vaccine following this week’s landmark announcement that it was effective in more than 90% of patients. The companies said deliveries of an initial order of 200 million vaccines will be subject to approval by European regulators and are expected to start by the end of this year.

Vaccines 105

Vaccines 105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

NOVEMBER 13, 2020

This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suppository dosed drugs…. The post Which pharmaceutical companies have the most suppository dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Dosage 52

Pharma Times

NOVEMBER 9, 2020

Conclusions made by a group of experts from academia and industry

116

116

Pharma Marketing Network

NOVEMBER 13, 2020

On November 12, 2020, The Pharma CX Tech Summit held their third annual conference. The topics focused on the emerging technologies that pharma is implementing to enhance customer experiences for patients, payers, and HCPs. These technologies include AI/ML, voice & chat, connected devices, AR/VR, automation, personalization, and telehealth. . During the summit, speakers shared their thoughts and opinions on new technologies, how to prioritize customer experiences during COVID-19, and their

Communication 52

Communication 52

pharmaphorum

NOVEMBER 13, 2020

Since Covid-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying on e-commerce and digital engagement to counterbalance the reduced ability for physical interactions. The pharma world is no exception, and this year both small and large players have made the transition – partly out of necessity – from a world that relied predominantly on the face-to-face side of doing business, into a new digital world.

Online Pharmacies 110

Online Pharmacies Pharmaceutical Companies Pharmaceutical Companies 110

Drug Patent Watch

NOVEMBER 13, 2020

Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two suppliers. There are three patents…. The post New patent expiration for Recordati Rare drug NEOPROFEN appeared first on DrugPatentWatch - Make Better Decisions.

52

52